tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jack Allen, 17 are a HOLD (20.48%), 66 are a BUY (79.52%).
Analyst Jack Allen, currently employed at BAIRD, carries an average stock price target met ratio of 39.17% that have a potential upside of 35.13% achieved within 70 days.
Jack Allen’s has documented 148 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CLLS, Cellectis SA at 15-Sep-2026.
Analyst best performing recommendations are on CRSP (CRISPR THERAPEUTICS AG).
The best stock recommendation documented was for ACLX (ARCELLX) at 4/13/2023. The price target of $39 was fulfilled within 8 days with a profit of $9.7 (33.11%) receiving and performance score of 41.38.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Apr-2026
$6
$4.5 (300.00%)
1 months 18 days ago
(17-Aug-2026)
1/11 (9.09%)
$3.92 (188.46%)
148
Buy Since 15-Apr-2026
$10
$8.5 (566.67%)
$10
5 months 13 days ago
(22-Apr-2026)
0/2 (0%)
$7.61 (318.41%)
Buy Since 04-Apr-2023
$11
$8.87 (416.43%)
$12
5 months 19 days ago
(16-Apr-2026)
0/12 (0%)
$8.63 (364.14%)
Sell Since 16-Apr-2026
5 months 19 days ago
(16-Apr-2026)
0/3 (0%)
$2.86 (55.64%)
Hold Since 21-Mar-2023
$3.85
$1.72 (80.75%)
$2.5
5 months 21 days ago
(14-Apr-2026)
2/3 (66.67%)
$1.13 (41.54%)
155
Which stock is Jack Allen most bullish on?
Which stock is Jack Allen most reserved on?
What Year was the first public recommendation made by Jack Allen?
